The recommended dose for individuals starting treatment with Trulicity is 0.75 mg injected (subcutaneously) under the skin in the arm, thigh, or abdomen once a week, preferably on the same time and day per week.
This dose may be increased in 1.5mg increments to facilitate better glycemic control, provided that patients remain on a 3mg weekly dosing for at least four weeks before increasing it to 4.5mg a week.
The 4.5mg dose once a week is the maximum dose a patient should be prescribed for with Trulicity.
Disclaimer: Please note that the contents of this community article are strictly for informational purposes and should not be considered as medical advice. This article, and other community articles, are not written or reviewed for medical validity by Canadian Insulin or its staff. All views and opinions expressed by the contributing authors are not endorsed by Canadian Insulin. Always consult a medical professional for medical advice, diagnosis, and treatment.